Cargando…

Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?

Blister or vesicant chemical warfare agents (CWAs) have been widely used in different military conflicts, including World War I and the Iran-Iraq War. However, their mechanism of action is not fully understood. Sulfur and nitrogen mustard exert toxic effects not only through the alkylation of thiol-...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero, Alejandro, Ramos, Eva, López-Muñoz, Francisco, De Los Ríos, Cristóbal, Egea, Javier, Gil-Martín, Emilio, Pita, René, Torrado, Juan J., Serrano, Dolores R., Juberias, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167553/
https://www.ncbi.nlm.nih.gov/pubmed/33920224
http://dx.doi.org/10.3390/diseases9020027
_version_ 1783701714877022208
author Romero, Alejandro
Ramos, Eva
López-Muñoz, Francisco
De Los Ríos, Cristóbal
Egea, Javier
Gil-Martín, Emilio
Pita, René
Torrado, Juan J.
Serrano, Dolores R.
Juberias, Antonio
author_facet Romero, Alejandro
Ramos, Eva
López-Muñoz, Francisco
De Los Ríos, Cristóbal
Egea, Javier
Gil-Martín, Emilio
Pita, René
Torrado, Juan J.
Serrano, Dolores R.
Juberias, Antonio
author_sort Romero, Alejandro
collection PubMed
description Blister or vesicant chemical warfare agents (CWAs) have been widely used in different military conflicts, including World War I and the Iran-Iraq War. However, their mechanism of action is not fully understood. Sulfur and nitrogen mustard exert toxic effects not only through the alkylation of thiol-bearing macromolecules, such as DNA and proteins, but also produce free radicals that can develop direct toxic effects in target organs such as the eyes, skin, and respiratory system. The lack of effective treatments against vesicant CWAs-induced injury makes us consider, in this complex scenario, the use and development of melatonin-based therapeutic strategies. This multifunctional indoleamine could facilitate neutralization of the oxidative stress, modulate the inflammatory response, and prevent the DNA damage, as well as the long-term health consequences mediated by vesicant CWAs-induced epigenetic mechanisms. In this context, it would be essential to develop new galenic formulations for the use of orally and/or topically applied melatonin for the prophylaxis against vesicant CWAs, as well as the development of post-exposure treatments in the near future.
format Online
Article
Text
id pubmed-8167553
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81675532021-06-02 Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option? Romero, Alejandro Ramos, Eva López-Muñoz, Francisco De Los Ríos, Cristóbal Egea, Javier Gil-Martín, Emilio Pita, René Torrado, Juan J. Serrano, Dolores R. Juberias, Antonio Diseases Review Blister or vesicant chemical warfare agents (CWAs) have been widely used in different military conflicts, including World War I and the Iran-Iraq War. However, their mechanism of action is not fully understood. Sulfur and nitrogen mustard exert toxic effects not only through the alkylation of thiol-bearing macromolecules, such as DNA and proteins, but also produce free radicals that can develop direct toxic effects in target organs such as the eyes, skin, and respiratory system. The lack of effective treatments against vesicant CWAs-induced injury makes us consider, in this complex scenario, the use and development of melatonin-based therapeutic strategies. This multifunctional indoleamine could facilitate neutralization of the oxidative stress, modulate the inflammatory response, and prevent the DNA damage, as well as the long-term health consequences mediated by vesicant CWAs-induced epigenetic mechanisms. In this context, it would be essential to develop new galenic formulations for the use of orally and/or topically applied melatonin for the prophylaxis against vesicant CWAs, as well as the development of post-exposure treatments in the near future. MDPI 2021-04-10 /pmc/articles/PMC8167553/ /pubmed/33920224 http://dx.doi.org/10.3390/diseases9020027 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Romero, Alejandro
Ramos, Eva
López-Muñoz, Francisco
De Los Ríos, Cristóbal
Egea, Javier
Gil-Martín, Emilio
Pita, René
Torrado, Juan J.
Serrano, Dolores R.
Juberias, Antonio
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
title Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
title_full Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
title_fullStr Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
title_full_unstemmed Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
title_short Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
title_sort toxicology of blister agents: is melatonin a potential therapeutic option?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167553/
https://www.ncbi.nlm.nih.gov/pubmed/33920224
http://dx.doi.org/10.3390/diseases9020027
work_keys_str_mv AT romeroalejandro toxicologyofblisteragentsismelatoninapotentialtherapeuticoption
AT ramoseva toxicologyofblisteragentsismelatoninapotentialtherapeuticoption
AT lopezmunozfrancisco toxicologyofblisteragentsismelatoninapotentialtherapeuticoption
AT delosrioscristobal toxicologyofblisteragentsismelatoninapotentialtherapeuticoption
AT egeajavier toxicologyofblisteragentsismelatoninapotentialtherapeuticoption
AT gilmartinemilio toxicologyofblisteragentsismelatoninapotentialtherapeuticoption
AT pitarene toxicologyofblisteragentsismelatoninapotentialtherapeuticoption
AT torradojuanj toxicologyofblisteragentsismelatoninapotentialtherapeuticoption
AT serranodoloresr toxicologyofblisteragentsismelatoninapotentialtherapeuticoption
AT juberiasantonio toxicologyofblisteragentsismelatoninapotentialtherapeuticoption